Aveanna Healthcare Holdings Announces Third Quarter 2024 Financial Results and Revised 2024 Outlook

Third Quarter Revenue was $509.0 million, a 6.5% increase over the prior year period Gross margin increased 8.4% to$ 159.7 million, compared to Q3 2023 Third Quarter Net loss was $42.8 million, compared to net loss of$ 102.4 million in the comparable prior year period Adjusted Net income was $4.6 million, an increase of$ 9.3 million over the comparable prior year period Adjusted EBITDA was $47.8 million, a 32.2% increase as compared to the prior year periodFull Year 2024 Revenue guidance raised to approxima ...